Article

Apolipoprotein M attenuates anthracycline cardiotoxicity and lysosomal injury

medRxiv · 2022 · Guo, Z.; Valenzuela Ripoll, C.; Picataggi, A.; Rawnsley, D. R.; Ozcan, M.; Chirinos, J. A.; Chendamarai, E.; Girardi, A.; Riehl, T.; Evie, H.; Diab, A.; Kovacs, A.; Hyrc, K.; Ma, X.; Asnani, A.; Shewale, S. V.; Scherrer-Crosbie, M.; Cowart, L. A.; Parks, J. S.; Zhao, L.; Gordon, D.; Ramirez-Valle, F.; Margulies, K. B.; Cappola, T. P.; Desai, A. A.; Pederson, L. N.; Bergom, C.; Stitziel, N. O.; Rettig, M. P.; DiPersio, J. F.; Hajny, S.; Christoffersen, C.; Diwan, A.; Javaheri, A.

Key facts

Title Apolipoprotein M attenuates anthracycline cardiotoxicity and lysosomal injury
First author Guo, Z.; Valenzuela Ripoll, C.; Picataggi, A.; Rawnsley, D. R.; Ozcan, M.; Chirinos, J. A.; Chendamarai, E.; Girardi, A.; Riehl, T.; Evie, H.; Diab, A.; Kovacs, A.; Hyrc, K.; Ma, X.; Asnani, A.; Shewale, S. V.; Scherrer-Crosbie, M.; Cowart, L. A.; Parks, J. S.; Zhao, L.; Gordon, D.; Ramirez-Valle, F.; Margulies, K. B.; Cappola, T. P.; Desai, A. A.; Pederson, L. N.; Bergom, C.; Stitziel, N. O.; Rettig, M. P.; DiPersio, J. F.; Hajny, S.; Christoffersen, C.; Diwan, A.; Javaheri, A.
Journal medRxiv
Published Mar 9, 2022
DOI 10.1101/2021.01.12.426397
Devices mentioned K021671, K220060
Product codes mentioned JIT, JJY, LBS

At a glance

  • 1–9 FDA submissions mentioned
  • 1–9 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature